Bariatric Surgery Candidate Clinical Trial
— EXPANTOfficial title:
Extended Pouch Gastric Bypass vs One-anastomosis Gastric Bypass in Patients With a BMI of 45 or Higher: a Randomized Controlled Trial
The classic RYGB is in most patients with a BMI ≥45 technically not feasible. Two alternatives are the Extended Pouch Gastric Bypass and the One Anastomosis gastric bypass. In this single blinded randomized controlled trial the investigators aim to establish which technique leads to more weightloss in bariatric patients with a BMI ≥45.
Status | Not yet recruiting |
Enrollment | 250 |
Est. completion date | December 1, 2029 |
Est. primary completion date | December 1, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion criteria: - BMI=45 - Bariatric guidelines Fried - Age 18-65 - Dedication to guided preoperative program - Intention to follow full postoperative program Exclusion criteria: - Secondary bariatric procedure - Medical(-related) cause for morbid obesity or fast weight gain (e.g. Cushing or medication related) - Inflammatory Bowel Disease (M. Crohn or Colitis Ulcerosa) - Renal function disorder (MDRD <30) or liver disease - Anticipated absence of yearly medical follow up - Does not speak Dutch language - Pregnancy |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
L. van Hogezand | Rijnstate Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Weightloss short term | percentage excess weight loss | 1, 3 and 5 years postoperatively | |
Secondary | Weightloss long term | percentage excess weight loss | 5-10 years postoperatively | |
Secondary | Complications short term | bleeding, leakage, infections, intra-abdominal abcess, readmission, mortality | up to 30 days postoperatively | |
Secondary | Complications long term | vitamin/electrolyte deficiencies, internal herniation, marginal ulceration | from 30 days until 10 years postoperatively | |
Secondary | Revision of the bypass | Surgical revision of bypass | until 10 years postoperatively | |
Secondary | Comorbidities | Reduction of obesity-related comorbidites: diabetes mellitus type 2, hypertension, hypercholesterolemia, joint aches en obstructive sleep apnea syndrome | until 10 years postoperatively | |
Secondary | Deficiencies in blood - red blood count | Blood samples: red blood count | until 10 years postoperatively | |
Secondary | Deficiencies in blood - vitamins | Blood samples vitamins | until 10 years postoperatively | |
Secondary | Deficiencies in blood - electrolytes | Blood samples: electrolytes | until 10 years postoperatively | |
Secondary | Reflux/dumping questionnaire | Questionnaires for reflux and dumping complaints. scales 0-10, higher is worse outcome | until 10 years postoperatively | |
Secondary | Health related quality of life questionnaire | Questionnaires on HrQoL and patient satisfaction of procedure, scales 0-5 and 0-10, higher is worse outcome | until 10 years postoperatively | |
Secondary | Peroperative complications | Peroperative complications: bleeding, iatrogenic complications | until 10 years postoperatively | |
Secondary | Number of patients with peroperative conversion to sleeve | Conversion to sleeve when bypass not feasible | until 10 years postoperatively |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Not yet recruiting |
NCT05536466 -
The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine
|
N/A | |
Active, not recruiting |
NCT04583683 -
Effects of Very Low Calorie Diet vs Metabolic Surgery on Weight Loss and Obesity Comorbidities
|
N/A | |
Completed |
NCT04099654 -
The Effect of Core Stabilization Exercise Program in Obese Subjects Awaiting Bariatric Surgery
|
N/A | |
Completed |
NCT03809182 -
Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.
|
Phase 4 | |
Completed |
NCT03638843 -
Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy - Part 2
|
N/A | |
Withdrawn |
NCT05845359 -
Intraoperative Methadone for Postoperative Pain Control
|
Phase 4 | |
Not yet recruiting |
NCT04343040 -
Perioperative Evaluation of Glucose Profile Using Continuous Glucose Monitoring System in Glucose Intolerant Patients
|
N/A | |
Withdrawn |
NCT03095404 -
Intravenous Lidocaine for Post-Operative Pain Control in Patients Undergoing Bariatric Bowel Surgery
|
Early Phase 1 | |
Recruiting |
NCT03100292 -
Korean OBEsity Surgical Treatment Study
|
N/A | |
Active, not recruiting |
NCT04357119 -
Common Limb Length in One-anastomosis Gastric Bypass
|
N/A | |
Completed |
NCT04883268 -
Focusing on Body Functionality After Bariatric Surgery
|
N/A | |
Completed |
NCT03210207 -
Gastric Plication in Mexican Patients
|
N/A | |
Completed |
NCT02300168 -
Neuromuscular Blockade: Outcome and Recovery for Laparoscopic Bariatric Surgery
|
N/A | |
Unknown status |
NCT01264120 -
The Impact of a Bariatric Rehabilitation Service on Patient Outcomes
|
N/A | |
Recruiting |
NCT03972319 -
Omega-3 Supplementation for LIver VolumE Reduction Study (OLIVER) Study
|
Early Phase 1 | |
Terminated |
NCT04626232 -
Comparison of the Sleeve Gastrectomy Technique With a Nissen Fundoplication Added to the Conventional Sleeve Gastrectomy Technique in Morbidly Obese Patients
|
N/A | |
Completed |
NCT03643783 -
Impact of Plasma Soluble Prorenin Receptor in Obese and Type 2 Diabetic Patients
|
||
Completed |
NCT04219852 -
Contraception and Bariatric Surgery: Evaluation of Contraception and Contraceptive Knowledge of Women Undergoing Bariatric Surgery at the University Hospital of Reims
|
||
Recruiting |
NCT05570474 -
Effect of Protein Supplementation on Fat Free Mass Preservation After Bariatric Surgery
|
N/A |